使用FDA不良事件报告系统进行药物诱导白内障的药物监测
Si-Yuan Hong1,2,3, Wen-Rui Lu1,2,3, Xiao-Dong Chen4
1Department of Ophthalmology, Provincial Clinical School of Fujian Medical University, Fuzhou, 350001, Fujian, China.
Scientific reports
|July 24, 2025
概括
药物诱导的白内障是视力丧失的重要原因之一. 这项研究确定了24种药物,包括葡萄糖皮质类药物和胰岛素类似物,与白内障风险增加有关,而二甲显示出最强的关联.
科学领域:
- 眼科医生 眼科 眼科
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 白内障是不可逆转的视力丧失的主要原因,特别是在老年人中.
- 药物诱导的白内障是视力障碍的一个未被认可的贡献者.
- 了解药物风险对于预防视力丧失至关重要.
研究的目的:
- 调查特定药物和白内障发展之间的关联.
- 识别高风险药物并分析它们的发病模式.
- 为临床决策和预防提供药监洞察力.
主要方法:
- 分析来自FDA不良事件报告系统 (FAERS) 的现实数据 (2004年第一季度 - 2024年第三季度).
- 包括2,336个白内障病例,涉及691种药物,年龄在0-45岁的人.
- 不成比例性分析以确定与白内障风险显著相关的药物.
主要成果:
- 24种药物与白内障风险的增加显著相关.
- 最高的风险与葡萄糖皮质类药物 (例如,酸),胰岛素类似物 (例如,胰岛素格拉金),尼提西和拉尼比祖马布有关.
- 双二甲酸盐 (BCPNN=7.83) 与最短的中位发病时间 (74天) 有着最强的关联. 抗瘤剂的平均发病时间最快 (533.89天).
结论:
- 这项研究确定了具有药物诱导白内障显著风险的特定药物.
- 这些发现强调了药物监测在检测和管理与药物相关的不良事件方面的重要性.
- 洞察力支持改善临床决策和预防白内障的策略.
相关概念视频
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
01:25Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
130
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
130
01:26Drug Administration and Therapy Phases: Overview
753
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
753